A lower plasma Ang II level after taking recombinant ACE2 may be safe in healthy volunteers and patients with acute respiratory distress syndrome or pulmonary arterial hypertension as demonstrated in the previous pilot studies (Haschke et al, 2013; Khan et al, 2017; Hemnes et al, 2018). This evidence concerns the gene AGT and pulmonary arterial hypertension.